Historical Stock Price
8% "No Withdrawal" Portfolio »    ACST Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
03/23/2020 $0.35 $0.35 $0.30 $0.31 654.70K
03/24/2020 $0.32 $0.34 $0.31 $0.33 620.20K
03/25/2020 $0.33 $0.38 $0.32 $0.36 884.20K
03/26/2020 $0.42 $0.42 $0.38 $0.41 1.08M
03/27/2020 $0.43 $0.43 $0.36 $0.40 562.10K
Acasti Pharma is a biopharmaceutical company focused on the research, development and commercialization of prescription drugs using omega-3 fatty acids (OM3) delivered both as free fatty acids and bound-to-phospholipid esters derived from krill oil. Co.'s primary product candidate is CaPre, an OM3 phospholipid therapeutic, which it is developing for the treatment of severe hypertriglyceridemia, a condition characterized by high or severe levels of triglycerides in the bloodstream.
ACST historical stock prices picture
Acasti Pharma (ACST) has the following price history information. Looking back at ACST historical stock prices for the last five trading days, on March 23, 2020, ACST opened at $0.35, traded as high as $0.35 and as low as $0.30, and closed at $0.31. Trading volume was a total of 654.70K shares. On March 24, 2020, ACST opened at $0.32, traded as high as $0.34 and as low as $0.31, and closed at $0.33. Trading volume was a total of 620.20K shares. On March 25, 2020, ACST opened at $0.33, traded as high as $0.38 and as low as $0.32, and closed at $0.36. Trading volume was a total of 884.20K shares. On March 26, 2020, ACST opened at $0.42, traded as high as $0.42 and as low as $0.38, and closed at $0.41. Trading volume was a total of 1.08M shares. On March 27, 2020, ACST opened at $0.43, traded as high as $0.43 and as low as $0.36, and closed at $0.40. Trading volume was a total of 562.10K shares.

ACST Historical Stock Prices By Date:

ACST historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Acasti Pharma shares, starting with a $10,000 purchase of ACST, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 02/07/2012
End date: 03/27/2020
Start price/share: $12.10
End price/share: $0.40
Dividends collected/share: $0.00
Total return: -96.69%
Average Annual Total Return: -34.23%
Starting investment: $10,000.00
Ending investment: $330.59
Years: 8.14
Date Close
03/23/2020$0.31
03/24/2020$0.33
03/25/2020$0.36
03/26/2020$0.41
03/27/2020$0.40
ACST is categorized under the Healthcare sector; below are some other companies in the same sector:

ACT Historical Stock Prices
ACUR Historical Stock Prices
ADHD Historical Stock Prices
ADK Historical Stock Prices
ADMA Historical Stock Prices
ADMP Historical Stock Prices
ADMS Historical Stock Prices
ADPT Historical Stock Prices
ADRO Historical Stock Prices
ADUS Historical Stock Prices

Also explore: ACST shares outstanding history

ACST Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2020, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.